{{Rsnum
|rsid=11171747
|Chromosome=12
|position=56124624
|Orientation=plus
|GMAF=0.3104
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 11.5 | 51.3 | 37.2
| HCB | 18.5 | 45.2 | 36.3
| JPT | 10.7 | 42.9 | 46.4
| YRI | 0.0 | 5.4 | 94.6
| ASW | 1.8 | 26.3 | 71.9
| CHB | 18.5 | 45.2 | 36.3
| CHD | 14.3 | 47.6 | 38.1
| GIH | 14.9 | 39.6 | 45.5
| LWK | 0.0 | 8.2 | 91.8
| MEX | 25.9 | 44.8 | 29.3
| MKK | 5.2 | 25.2 | 69.7
| TSI | 11.8 | 52.0 | 36.3
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21779181
|Trait=None
|Title=Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy.
|RiskAllele=
|Pval=6E-8
|OR=1.2300
|ORtxt=[1.14-1.33]
|OA=1
}}

{{PMID|19956108|OA=1
}} Analysis of 55 autoimmune disease and type II diabetes loci: further confirmation of chromosomes 4q27, 12q13.2 and 12q24.13 as type I diabetes loci, and support for a new locus, 12q13.3-q14.1.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}